Litcius/Paper detail

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu, Omar Abdel‐Wahab, Justin Taylor, David P. Steensma, Daniel T. Starczynowski, Mikkael A. Sekeres, Guillermo Sanz, David A. Sallman, Gail J. Roboz, Uwe Platzbecker, Mrinal M. Patnaik, Eric Padron, Olatoyosi Odenike, Stephen D. Nimer, Aziz Nazha, Ravindra Majeti, Sanam Loghavi, Richard F. Little, Alan F. List, Tae Kon Kim, Christopher S. Hourigan, Robert P. Hasserjian, Stephanie Halene, Elizabeth A. Griffiths, Steven D. Gore, Peter L. Greenberg, María E. Figueroa, Pierre Fenaux, Fabio Efficace, Amy E. DeZern, Naval Daver, Jane E. Churpek, Hetty E. Carraway, Rena Buckstein, Andrew M. Brunner, Jacqueline Boultwood, Uma Borate, Rafael Bejar, John M. Bennett, Andrew H. Wei, Valeria Santini, Michael R. Savona, Amer M. Zeidan

2023Blood Reviews31 citationsDOIOpen Access PDF

Topics & Concepts

Myelodysplastic syndromesMedicineRisk stratificationRisk assessmentInternational Prognostic Scoring SystemIntensive care medicineInternal medicineComputer scienceComputer securityBone marrowAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentNeutropenia and Cancer Infections